EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement

Reinhold Kreutz, Ali Canbay, Martin Haluzik, Andrzej Januszewicz, Juan M Mendive, Pantelis Sarafidis, Jörn M Schattenberg

European Journal of Internal Medicine · 2026-08 · 150 · 106902

DOI: 10.1016/j.ejim.2026.106902 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2026-08. Verfasst von Reinhold Kreutz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Charité -University Medicine, Department of Clinical Pharmacology and Toxicology, Berlin, Germany. Electronic address: reinhold.kreutz@charite.de. Hauptthemen laut MEDLINE: Metabolic Syndrome, Cardio-Renal Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recently introduced cardiovascular-kidney-metabolic (CKM) syndrome captures the close interplay between metabolic risk factors, chronic kidney disease, and cardiovascular disease, but insufficiently reflects the important additional role of the liver. Metabolic dysfunction-associated steatotic liver disease (MASLD), the most prevalent chronic liver disease worldwide, is strongly associated with cardiovascular events, kidney disease progression, and all-cause mortality, yet remains frequently under-recognized in routine clinical practice. We propose the concept of a cardiovascular-kidney-liver-metabolic syndrome (CKLMS) and present a multidisciplinary, primary care-centered framework for its assessment and management. Based on expert consensus and current evidence, the framework integrates cardiovascular, renal, hepatic, and metabolic risk stratification using accessible, validated tools feasible in primary care, including blood pressure and lipid profiling, assessment of kidney function and albuminuria, non-invasive liver fibrosis testing, and systematic screening for diabetes and obesity. Management emphasizes early lifestyle intervention, use of pharmacological therapies with multi-organ benefit, and clearly defined referral pathways to specialist care. Primary care professionals are positioned as coordinators of longitudinal, patient-centered, multidisciplinary management. Early, integrated identification and treatment of CKLMS in primary care represents a pragmatic and effective strategy to prevent disease progression, reduce cardiovascular and kidney events, and improve long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeCardio-Renal SyndromeCardiovascular DiseasesHumansPrimary Health CareRisk FactorsObesityRisk Assessment

Stichwörter der Autor:innen

Blood pressureCardiovascular riskCardiovascular-kidney-metabolic syndrome (CKM)DiabetesHypertensionKidneyLiverMetabolic dysfunction associated steatotic liver disease (MASLD)Obesity

Autor:innen und Institutionen

  • Charité -University Medicine, Department of Clinical Pharmacology and Toxicology, Berlin, Germany. Electronic address: reinhold.kreutz@charite.de.
  • Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.
  • Diabetes Centre, Institute for Clinical and Experimental Medicine in Prague, Czech Republic.
  • Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.
  • La Mina Primary Health Care Academic Centre, University of Barcelona, Spain.
  • 1st Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

Zitieren

APA

Kreutz, R., Canbay, A., Haluzik, M., Januszewicz, A., Mendive, J. M., Sarafidis, P., & Schattenberg, J. M. (2026). Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement. European Journal of Internal Medicine, 150, 106902. https://doi.org/10.1016/j.ejim.2026.106902

Vancouver

Kreutz R, Canbay A, Haluzik M, Januszewicz A, Mendive JM, Sarafidis P, et al. Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement. European Journal of Internal Medicine. 2026;150:106902. doi:10.1016/j.ejim.2026.106902

BibTeX
@article{Kreutz2026,
  author = {Kreutz, Reinhold and Canbay, Ali and Haluzik, Martin and Januszewicz, Andrzej and Mendive, Juan M and Sarafidis, Pantelis and Schattenberg, Jörn M},
  title = {Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement},
  journal = {European Journal of Internal Medicine},
  year = {2026},
  volume = {150},
  pages = {106902},
  doi = {10.1016/j.ejim.2026.106902}
}
Kostenlos starten →